REFERENCES
- Ford J. L. The Current Status of Solid Dispersions. Pharm. Acta Helv. 1986; 61(3)69–88
- Bloch D. W., Speiser P. Solid Dispersions—Fundamentals and Examples. Pharm. Acta Helv. 1987; 62(1)23–27
- Ito S., Demachi M., Toriumi Y., Adachi T., Itai S., Hirayama F., Uekama K. Improvement of Dissolution Characteristicism of a New Chalcon Derivative, SU-740: Comparison Between Size Reduction, Solid Dispersion and Inclusion Complexation. Chem. Pharm. Bull. 1995; 43(12)2221–2225
- Lovrecich M., Nobile F., Rubessa F., Zingone G. Effect of Ageing on the Release of Indomethacin from Solid Dispersions with Eudragits. Int. J. Pharm. 1996; 131: 247–255
- Vudathala G. K., Rogers J. A. Oral Bioavailability of Griseofulvin from Aged Griseofulvin: Lipid Coprecipitates: In Vivo Studies in Rats. J. Pharm. Sci. 1992; 81(12)1166–1169
- Dargel E., Mielck J. B. Chemical Stability of Drugs in Solid Dispersions: Accelerated Test of Reserpine Dispersed in Kollidon® 25 and Eudragit® E. Pharm. Technol. 1989; 35(4)197–209
- Frontini R., Mielck J. B. Interactions Between Bendroflumethiazide and Water Soluble Polymers. III. Chemical Degradation. Eur. J. Pharm. Biopharm. 1997; 44: 85–88
- Frömming K.-H., Heyer K., Hosemann R. Schmelzeinbettung des Griseofulvins in Pluronic F68. Dtsch. Apoth. Ztg. 1981; 121(42)2276–2280
- Lheritier J., Chauvet A., Abramovici B., Masse J. Improvement of the Dissolution Kinetics of SR 33557 by Means of Solid Dispersions Containing PEG 6000. Int. J. Pharm. 1995; 123: 273–279
- Kai T., Akiyama Y., Nomura S., Sato M. Oral Absorption Improvement of Poorly Water Soluble Drug Using Solid Dispersion Technique. Chem. Pharm. Bull. 1996; 4(3)5568–5571
- Kedzierewicz F., Villieras F., Zinutti C., Hoffman M., Maincent P. A 3-Year Stability Study of Tolbutamide Solid Disperions and β-Cyclodextrin Complex. Int. J. Pharm. 1995; 117: 247–251
- Shalev E. Y., Zografi C. How Does Residual Water Affect the Solid State Degradation of Drugs in the Amorphous State ?. J. Pharm. Sci. 1996; 85(11)1137–1140
- Hülsmann S., Backensfeld T., Keitel S., Bodmeier R. Melt Extrusion—An Alternative Method for Enhancing the Dissolution Rate of 17β-Estradiol Hemihydrate. Eur. J. Pharm. Biopharm. 2000; 49: 237–242
- Aitken-Nichol C., Zhang F., McGinity J. Hot Melt Extrusion of Acrylic Films. Pharm. Res. 1996; 13(5)804–808
- Adel El-Egakey M., Soliva M., Speiser P. Hot Extruded Dosage Forms. Pharm. Acta Helv. 1971; 46: 31–52
- Lundberg B. Temperature Effect on the Water Solubility and Water Octanol Partition of Some Steroids. Acta Pharm. Suec. 1979; 16: 151–159
- Kabasakalian P., Britt M., Yudis M. D. Solubility of Some Steroids in Water. J. Pharm. Sci. 1966; 55: 642
- CH Topic Q1A. Stability Testing Guidelines: Stability Testing of New Drug Substances and Products. Dec. 1993
- Nyquist H. Int. J. Pharm. Tech. & Prod. Mfr. 1983; 4(2)47–48
- Duddu S. P., Weller K. Importance of the Glass Transition Temperature in Accelerated Stability Testing of Amorphous Solids: Case Study Using Lyophilized Aspirin Formulation. J. Pharm. Sci. 1996; 85(3)345–347
- Obikili A., Deyme M., Wouessidjewe D., Duchêne D. Improvement of Aqueous Solubility and Dissolution Kinetics of Canrenone by Solid Dispersions in Sucroester. Drug Dev. Ind. Pharm. 1988; 14(6)791–803
- Saleki-Gerhardt A., Ahlneck C., Zografi G. Assessment of Disorder in Crystalline Solids. Int. J. Pharm. 1994; 101: 237–247
- Ahlneck C., Zografi G. The Molecular Basis of Moisture Effects on the Physical and Chemical Stability of Drugs in the Solid State. Int. J. Pharm. 1995; 123: 265–271
- Buckton G., Darcy P. The Use of Gravimetric Studies to Assess the Degree of Crystallinity of Predominantly Crystalline Powders. Int. J. Pharm. 1995; 123: 265–271